Focus and Scope

The journal focuses on the understanding that the Asia-Pacific region presents unique genetic, environmental, and lifestyle factors that significantly influence cancer incidence, progression, and outcomes. As such, APJCR is dedicated to advancing knowledge in these areas by publishing rigorous and relevant scientific research.

 

Submissions to APJCR are reviewed under a broad scope of topics crucial to experimental and clinical cancer research. The journal accepts original research articles, case reports, and review articles that contribute to the advancement of cancer science, and they are written in English. All submitted manuscripts undergo a thorough double-blind peer review process, ensuring that reviewers and authors remain anonymous to each other, followed by a comprehensive Editorial review. This rigorous review process upholds the journal's high standards and ensures the publication of only the most significant and well-conducted studies.

 

The journal's focus and scope include, but are not limited to, the following areas:

  • Cancer Management: Research on strategies and protocols for effective cancer care, encompassing multidisciplinary approaches that integrate surgery, chemotherapy, radiation, and emerging therapies.
  • Cancer Prevention: Studies on primary and secondary prevention methods, including lifestyle interventions, vaccination programs, and screening strategies tailored to the Asia-Pacific population.
  • Cancer Etiology: Research exploring the causes and risk factors of cancer, focusing on understanding genetic predispositions, environmental exposures, and infectious agents prevalent in the region.
  • Epidemiology: Epidemiological studies that map the incidence, distribution, and determinants of cancer in the Asia-Pacific providing crucial data for public health planning and resource allocation.
  • Molecular Oncology: Investigations into the molecular and cellular mechanisms of cancer, including genetic mutations, signal transduction pathways, and the role of non-coding RNAs in tumorigenesis.
  • Cancer Diagnosis and Therapy: Research on advanced diagnostic techniques, biomarkers, and innovative therapeutic approaches, including targeted therapies, immunotherapies, and personalized medicine.
  • Tumor Pathology: Studies on the pathology of tumors, including morphological, histological, and molecular characterization, are essential for accurate diagnosis and treatment planning.
  • Surgical Oncology: Research focused on surgical techniques, outcomes, and innovations in cancer management, particularly in the context of the Asia-Pacific's unique patient populations.
  • Medical Oncology: Studies on the pharmacological management of cancer, including chemotherapy, hormone therapy, and emerging drug therapies.
  • Radiation Oncology: Research on the application of radiation therapy in cancer treatment, including advancements in radiotherapy techniques and their efficacy in Asia-Pacific.
  • Interventional Radiology: Studies on minimally invasive, image-guided procedures used in the diagnosis and treatment of cancer, offering alternatives to traditional surgical methods.
  • Early Detection: Research on early detection methods and screening programs, particularly those tailored to the unique epidemiological profiles of the Asia-Pacific region, aiming to improve early diagnosis and outcomes.


APJCR is committed to fostering a collaborative environment for researchers, clinicians, and public health professionals across the globe, with a particular focus on issues pertinent to the Asia-Pacific. The journal aims to be a comprehensive resource, providing valuable insights and knowledge that drive cancer prevention, diagnosis, treatment, and care innovations. Through its rigorous peer-review process and broad scope, APJCR ensures that its published content contributes to the global body of cancer research and addresses the specific needs and challenges of the Asia-Pacific region.